Countdown to the biggest trade of my 25 yr career

Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.

Click here to see the surprising reason why

ATXS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.90%

Insider Buying (Last 12 Months): $34,587,521.50

Insider Selling (Last 12 Months): $111,396.00

Astria Therapeutics Insider Trading History Chart

Astria Therapeutics Share Price & Price History

^$11.32

▲ +0.14 (1.25%)

As of 11/1/2024 01:00 AM ET

Days: 30 | 90 | 365

Banking failure dead ahead

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

Astria Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/1/2024	Perceptive Advisors Llc	Director	Buy	2,481,350	$12.09	$29,999,521.50	4,873,721
1/29/2024	Christopher Morabito	insider	Sell	9,200	$11.15	$102,580.00
1/26/2024	Christopher Morabito	insider	Sell	800	$11.02	$8,816.00
12/21/2023	Perceptive Advisors Llc	Director	Buy	740,000	$6.20	$4,588,000.00	2,392,371
10/16/2023	Perceptive Advisors Llc	Director	Buy	1,074,608	$6.51	$6,995,698.08	1,652,371
12/19/2022	Perceptive Advisors Llc	Director	Buy	908,265	$11.01	$9,999,997.65	1,038,309
11/19/2021	Andrew Komjathy	Insider	Buy	100	$6.70	$670.00

Ex WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction

From Paradigm Press | Ad

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

SEC Filings (Institutional Ownership Changes) for Astria Therapeutics (NASDAQ:ATXS)

98.98% of Astria Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Astria Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/3/2024	SG Americas Securities LLC	14,078	$0.16M	0.0%	N/A	0.026%
9/16/2024	Cubist Systematic Strategies LLC	281,410	$2.56M	0.0%	N/A	0.499%
8/27/2024	Logos Global Management LP	500,000	$4.55M	0.4%	-77.7%	0.911%
8/20/2024	Nantahala Capital Management LLC	675,000	$6.14M	0.4%	N/A	1.229%
8/16/2024	Driehaus Capital Management LLC	1,749,922	$15.92M	0.2%	-0.9%	3.187%
8/15/2024	Susquehanna Fundamental Investments LLC	44,000	$0.40M	0.0%	N/A	0.080%
8/15/2024	Millennium Management LLC	1,842,063	$16.76M	0.0%	+13.5%	3.355%
8/15/2024	Affinity Asset Advisors LLC	975,606	$8.88M	1.0%	+15.4%	1.777%
8/14/2024	Cubist Systematic Strategies LLC	281,410	$2.56M	0.0%	N/A	0.512%
8/14/2024	Logos Global Management LP	500,000	$4.55M	0.4%	-77.7%	0.911%
8/14/2024	Profund Advisors LLC	20,399	$0.19M	0.0%	-17.7%	0.037%
8/12/2024	Hsbc Holdings PLC	18,773	$0.17M	0.0%	N/A	0.034%
8/10/2024	Sofinnova Investments Inc.	60,692	$0.55M	0.0%	N/A	0.111%
8/9/2024	Renaissance Technologies LLC	22,461	$0.20M	0.0%	-45.7%	0.041%
8/9/2024	Dimensional Fund Advisors LP	146,158	$1.33M	0.0%	+1,043.7%	0.266%
8/7/2024	ClariVest Asset Management LLC	80,315	$0.73M	0.1%	N/A	0.146%
8/6/2024	Quest Partners LLC	3,206	$29K	0.0%	+3,310.6%	0.006%
8/1/2024	Rhumbline Advisers	65,375	$0.60M	0.0%	+4.1%	0.119%
7/29/2024	Panagora Asset Management Inc.	30,926	$0.28M	0.0%	+104.7%	0.056%
7/26/2024	Bank of New York Mellon Corp	139,071	$1.27M	0.0%	+6.9%	0.253%
5/20/2024	Virtu Financial LLC	30,313	$0.43M	0.0%	N/A	0.055%
5/17/2024	RA Capital Management L.P.	4,413,150	$62.12M	0.8%	N/A	8.037%
5/17/2024	Artal Group S.A.	884,214	$12.45M	0.3%	N/A	1.610%
5/17/2024	Tidal Investments LLC	118,200	$1.66M	0.0%	N/A	0.215%
5/15/2024	Price T Rowe Associates Inc. MD	14,203	$0.20M	0.0%	N/A	0.026%
5/15/2024	Affinity Asset Advisors LLC	845,606	$11.90M	1.5%	-42.3%	1.540%
5/14/2024	StemPoint Capital LP	230,273	$3.24M	0.9%	-73.1%	0.419%
5/14/2024	American International Group Inc.	24,565	$0.35M	0.0%	+49.4%	0.045%
5/13/2024	Ameritas Investment Partners Inc.	4,971	$70K	0.0%	+135.6%	0.009%
5/10/2024	Vanguard Group Inc.	2,535,891	$35.69M	0.0%	+23.4%	4.618%
5/7/2024	Oppenheimer & Co. Inc.	12,944	$0.18M	0.0%	-10.4%	0.024%
4/22/2024	Vivo Capital LLC	2,329,027	$32.78M	2.6%	-6.2%	4.242%
2/26/2024	Perceptive Advisors LLC	4,004,070	$30.75M	0.7%	+82.9%	9.032%
2/14/2024	ADAR1 Capital Management LLC	191,251	$1.47M	0.5%	N/A	0.431%
2/13/2024	Armistice Capital LLC	1,578,000	$12.12M	0.2%	N/A	3.560%
2/13/2024	Affinity Asset Advisors LLC	1,466,465	$11.26M	2.1%	+46.6%	3.308%
2/9/2024	Trexquant Investment LP	53,204	$0.41M	0.0%	N/A	0.120%
2/8/2024	Panagora Asset Management Inc.	15,462	$0.12M	0.0%	N/A	0.035%
2/7/2024	Vivo Capital LLC	2,482,727	$19.07M	1.6%	+47.7%	5.601%
2/6/2024	AJOVista LLC	6,636	$51K	0.1%	N/A	0.015%
11/15/2023	Affinity Asset Advisors LLC	1,000,300	$7.46M	2.1%	+53.7%	3.567%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	42,070	$0.31M	0.0%	-20.1%	0.150%
11/13/2023	FMR LLC	2,565,052	$19.14M	0.0%	-13.4%	9.148%
11/7/2023	Jump Financial LLC	14,926	$0.11M	0.0%	N/A	0.053%
10/24/2023	Stratos Wealth Partners LTD.	42,188	$0.32M	0.0%	-32.6%	0.150%
9/21/2023	Barclays PLC	9,010	$75K	0.0%	-72.7%	0.032%
8/21/2023	Affinity Asset Advisors LLC	650,875	$5.42M	1.9%	+23.0%	2.321%
8/15/2023	Sphera Funds Management LTD.	471,018	$3.92M	0.6%	+11.9%	1.680%
8/14/2023	Deep Track Capital LP	1,697,415	$14.14M	0.7%	-6.6%	6.054%
8/14/2023	Driehaus Capital Management LLC	1,455,648	$12.13M	0.2%	+1.6%	5.191%
8/4/2023	American International Group Inc.	12,296	$0.10M	0.0%	N/A	0.044%
8/3/2023	Oppenheimer & Co. Inc.	14,527	$0.12M	0.0%	-9.4%	0.052%
7/25/2023	Raymond James & Associates	12,308	$0.10M	0.0%	N/A	0.044%
7/18/2023	Stratos Wealth Partners LTD.	62,613	$0.52M	0.0%	N/A	0.223%
5/16/2023	Altium Capital Management LP	1,347,088	$17.92M	9.9%	-1.2%	4.807%
5/15/2023	Affinity Asset Advisors LLC	529,369	$7.04M	2.3%	+12.0%	1.889%
5/15/2023	Logos Global Management LP	1,044,960	$13.90M	2.0%	+20.8%	3.729%
5/12/2023	Mirabella Financial Services LLP	28,585	$0.38M	0.1%	N/A	0.102%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	37,519	$0.50M	0.0%	+112.6%	0.134%
5/4/2023	Barclays PLC	32,997	$0.44M	0.0%	N/A	0.118%
2/15/2023	Fairmount Funds Management LLC	1,901,397	$28.31M	4.5%	+108.5%	11.300%
2/14/2023	683 Capital Management LLC	14,718	$0.22M	0.0%	N/A	0.087%
2/14/2023	Driehaus Capital Management LLC	1,337,315	$19.91M	0.3%	+103.7%	7.946%
2/14/2023	Dorsey Wright & Associates	2,270	$34K	0.0%	N/A	0.013%
2/13/2023	Vivo Capital LLC	1,681,199	$25.03M	2.9%	+68.1%	9.989%
2/10/2023	Opaleye Management Inc.	261,703	$3.90M	1.4%	+96.0%	1.555%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	17,644	$0.26M	0.0%	N/A	0.105%
2/9/2023	Saturn V Capital Management LLC	169,493	$1.56M	1.3%	N/A	1.007%
2/8/2023	Oppenheimer & Co. Inc.	16,016	$0.24M	0.0%	-10.1%	0.095%
11/15/2022	Tri Locum Partners LP	631,579	$5.71M	1.6%	N/A	3.754%
11/14/2022	Cormorant Asset Management LP	1,200,000	$10.85M	0.8%	+300.0%	9.219%
11/14/2022	Vivo Capital LLC	1,000,000	$9.04M	1.0%	N/A	7.682%
11/14/2022	Boothbay Fund Management LLC	101,619	$0.92M	0.0%	+34.1%	0.781%
11/14/2022	Altium Capital Management LP	445,000	$4.02M	1.5%	N/A	3.419%
11/14/2022	Oppenheimer & Co. Inc.	17,816	$0.16M	0.0%	-24.6%	0.137%
11/14/2022	Ghost Tree Capital LLC	500,000	$4.52M	1.3%	N/A	3.841%
11/7/2022	Jump Financial LLC	12,000	$0.11M	0.0%	N/A	0.092%
8/12/2022	Ikarian Capital LLC	592,123	$1.78M	0.3%	+542.1%	4.549%
2/2/2022	Oppenheimer & Co. Inc.	21,816	$0.12M	0.0%	+78.1%	0.168%
12/3/2021	Perceptive Advisors LLC	1,959,652	$17.32M	0.2%	N/A	15.064%
11/16/2021	VR Adviser LLC	538,999	$4.77M	0.6%	N/A	13.806%
11/16/2021	Commodore Capital LP	239,270	$2.12M	0.6%	N/A	6.129%
11/15/2021	RA Capital Management L.P.	1,262,193	$11.16M	0.2%	N/A	32.331%
11/15/2021	GSA Capital Partners LLP	24,996	$0.22M	0.0%	N/A	0.640%
11/12/2021	Renaissance Technologies LLC	109,353	$0.97M	0.0%	N/A	2.801%
11/12/2021	Oppenheimer & Co. Inc.	12,249	$0.11M	0.0%	N/A	0.314%
11/12/2021	Botty Investors LLC	28,247	$0.25M	0.1%	N/A	0.724%
11/12/2021	Artal Group S.A.	33,333	$0.30M	0.0%	N/A	0.854%
11/9/2021	BlackRock Inc.	41,116	$0.36M	0.0%	N/A	1.054%
9/3/2021	Parametric Portfolio Associates LLC	115,069	$0.24M	0.0%	-32.8%	2.947%
8/18/2021	Ikarian Capital LLC	532,298	$1.12M	0.1%	-37.6%	2.273%
8/17/2021	Logos Global Management LP	3,190,000	$6.73M	0.6%	N/A	13.623%
8/17/2021	Millennium Management LLC	461,609	$0.97M	0.0%	N/A	1.971%
8/17/2021	Acuta Capital Partners LLC	1,173,674	$2.48M	1.0%	N/A	5.012%
8/17/2021	Boothbay Fund Management LLC	84,000	$0.18M	0.0%	-11.9%	0.359%
8/17/2021	Boxer Capital LLC	1,775,000	$3.75M	0.1%	N/A	7.580%
8/16/2021	Squarepoint Ops LLC	12,388	$26K	0.0%	N/A	0.053%
8/16/2021	Corient Capital Partners LLC	55,334	$0.12M	0.0%	-46.5%	0.236%
8/16/2021	Commodore Capital LP	1,617,000	$3.41M	1.2%	N/A	6.905%
8/16/2021	Occudo Quantitative Strategies LP	35,066	$74K	0.0%	N/A	0.150%

Data available starting January 2016

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in Phase 1b/2 clinical trials for the treatment of hereditary angioedema. The company is also developing STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, an immune disorder associated with loss of skin barrier function and itching. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $11.32

$11.03

$11.39

50 Day Range

MA: $11.54

$10.50

$12.65

52 Week Range

Now: $11.32

$4.26

$16.90

Volume

341,434 shs

Average Volume

632,824 shs

Market Capitalization

$638.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.71

Who are the company insiders with the largest holdings of Astria Therapeutics?: Astria Therapeutics' top insider investors include:
Perceptive Advisors Llc (Director)
Christopher Morabito (Insider)
Learn More about top insider investors at Astria Therapeutics.
Who are the major institutional investors of Astria Therapeutics?: Astria Therapeutics' top institutional shareholders include:
SG Americas Securities LLC — 0.03%
Learn More about top institutional investors of Astria Therapeutics stock.
Which major investors are buying Astria Therapeutics stock?: Within the last quarter, ATXS stock was acquired by institutional investors including:
SG Americas Securities LLC